$MRNA I wonder what percentage of world population will have access to these RNA vaccines (MRNA, $PFE/ $BNTX) given the logistic challenges of keeping vaccine stable in transport (need super cool temps, otherwise vaccine is useless). If we cannot vaccinate a majority of world population, we will have a drawn out pandemic with multiple fires that need to be put out, which will of course impact global economic output. That’s why I think ultimately NVAX will end up being the big winner. No doubt, there will likely be money to be made with news momentum coming this week. Just my two cents.
  • 2